Research Line

From the laboratory to the bedside: a multidisciplinary program to reduce the impact of cardio-respiratory diseases /
Infectious Diseases

Antimicrobial resistance
Design, development, and management of spontaneous and sponsored clinical trials in the area of antimicrobial resistance.

Translational research applied to infectious diseases
Immune, microbiological, and microbiota characterization in infections in the immunocompetent host (sepsis, pneumonia, nontuberculous mycobacteriosis) and in the immunocompromised host.

HIV infection
Design, development and management of spontaneous and sponsored clinical trials in the area of pathogenesis, treatment and prevention of HIV infection, including as an opportunity to offer patients innovative therapies.

Emerging viral infections
Design, development and management of spontaneous and sponsored clinical trials in the area of pathogenesis, treatment and prevention (vaccines, monoclonal antibodies) of SARS-CoV-2 infection, including as an opportunity to offer patients innovative therapies.

  • IRCCS San Gerardo dei Tintori Foundation, Monza
  • IRCCS Humanitas Research Hospital, Rozzano
  • ASST Papa Giovanni XXIII, Bergamo
  • ASST Lecco Hospital A. Manzoni, Lecco
  • ASST Grande Ospedale Metropolitano Niguarda, Milan
  • IRCCS San Raffaele Hospital, Milan
  • ASST Fatebenefratelli Sacco, Milan
  • University of Insubria, Varese 
  • ASST Santi Paolo e Carlo, Milan
  • ASST Maggiore Hospital, Lodi
  • University of Brescia
  • ASST Mantua Carlo Poma Hospital
  • ASST Cremona
  • ASST Olona Valley
  • Busto Arsizio Hospital
  • ASST Lariana
  • IRCCS Policlinico San Matteo Foundation Pavia
  • ASST West Milanese
  • Policlinico di Sant'Orsola, Bologna
  • Cattaneo University LIUC, Castellanza 
  • IRCCS Mario Negri Pharmacological Institute, Milan
  • University of Verona
  • University of Zurich, Switzerland
  •  University Medical Center Utrecht, The Netherlands
  • Policlinico Universitario A. Gemelli, Rome
  • IRCCS Ospedale Sacro Cuore Don Calabria Negrar, Verona, Italy,
  • Azienda Ospedaliera Integrata, Verona
  • National Institute of Molecular Genetics, Milan, Italy
  • National Institute of Health
  • University of Parma
  • University of Sassari
  • University of Milan
  • Anlaids Onlus National
  • The Bridge Foundation
  • Aarhus University Medical Center, Aarhus, Denmark
  • Chelsea and Westminster Hospital, London, UK
  • Erasmus University Medical Center, Rotterdam, Netherlands
  • Ghent University Academic Center, Ghent, Belgium
  • IrsiCaixa, Barcelona, Spain
  • Imperial College, London, UK
  • Oxford University, UK
  • Karolinska Institute, Stockholm, Sweden
  • Queen Mary University Center, London, UK
  • Guys and St Thomas, Barts Healthcare QMUL
  • IRCCS Mario Negri Pharmacological Institute, Milan, Italy
  • MACH University of Milan, Italy
  • University College of London
  • Universitatsklinikum Heidelberg, Fundacion Privada Instituto de Salud Global Barcelona, Spain
  • Fundacio Institut Universitari per la Recerca a l'Atencio primaria de Salut Jorgi Gol i Gurina, Spain
  • Norwegian Institute of Public Health, Norway
  • Stichting Amsterdam Institute for Global Health and Development, Netherlands
  • Nigeria Centre for Disease Control and Prevention, Nigeria
  • Université de Genève, Switzerland
  • Public Health Foundation of India
  • Fundacao de Medicina Tropical do Amazones, Brazil
  • Laboratoire National de Santé, Luxembourg
  • Arab American University Private Stock Compan, Palestine
  • Institut de Investigacio en Ciencies de la Salut German Trias i Pujol, Spain
  • Dopasi Foundation, Pakistan
  • University of the Philippines System, Philippines
  • Fundacao Manhica, Mozambique
  • Drugs for Neglected Diseases Initiative Fondation, Switzerland

1 associate professor of infectious diseases, 12 infectivologists, 8 research fellows, 2 contractors